JAMA Dermatology —The Year in Review, 2025
By
Kanade Shinkai
May 1, 2026
Clinical Scorecard: JAMA Dermatology: Highlights and Developments from 2025
At a Glance
Category Detail
Condition Dermatologic conditions Key Mechanisms Focus on evidence-based practices, AI integration, and timely publication Target Population Patients with skin diseases, including skin cancer and atopic dermatitis Care Setting Dermatology clinics and research institutions
Key Highlights
3413 manuscripts evaluated with a 7% acceptance rate Median days from acceptance to publication reduced to 63 days High impact factor of 11 with over 11.2 million article views Notable studies on nicotinamide for skin cancer prevention and AI in dermatology Increased focus on climate change impacts on dermatologic health Guideline-Based Recommendations
Diagnosis
Utilize AI-guided risk stratification tools for skin cancer Consider total-body photography for high-risk melanoma detection Management
Recommend daily emollient use in infants to reduce atopic dermatitis incidence Evaluate the efficacy of novel treatments like next-generation bruton tyrosine kinase inhibitors Monitoring & Follow-up
Monitor the impact of AI-enabled devices on patient care and outcomes Risks
Assess potential overdiagnosis in melanoma screening practices Patient & Prescribing Data
Individuals at risk for skin cancer and those with atopic dermatitis
Nicotinamide supplementation shows promise for secondary prevention of skin cancer
Clinical Best Practices
Encourage rigorous evaluation of dermatologic studies to advance literature Promote collaboration with AI technologies to enhance patient care Incorporate qualitative studies to understand patient experiences in skin disease management Related Resources & Content
